Aarkstore Enterprise - The Pharmaceutical Wholesale And Distribution Industry Outlook & Analysis 2

The Pharmaceutical Wholesale and Distribution Industry Outlook & Analysis 2008

The major problem facing the Wholesale & Distribution industry is its low profit margin which is in the region of only 1-2%. However, this market is entering into a crucial period with many key products losing patent protection, facing heavy generic competition. As generics are priced lower than their branded counterparts, the actual dollar profit on them taken by W&D companies, for their movement, is reduced. In the light of this, other key factors such as new pricing and distribution models are also discussed in more detail. Other important issues that are affecting the industry and discussed in detail include:

1. Drug Counterfeiting

2. Direct-to-Pharmacy Distribution

3. Parallel Trade

4. Canada and US Drug Reimportation

5. Internet drugs: Mail Order and On-line Pharmacies.

The objectives of this report are to understand the W&D industry, why it occurs, who it affects, different natures of wholesale-distribution and what kinds of strategies are involved. Wholesale-Distribution has both pros and cons for different healthcare stakeholders. Wholesale-Distribution is a complex area, where there are many grey areas.

In particular, The Pharmaceutical Wholesale and Distribution Sector concentrates on the following essential aspects of the industry:

Discussion of the current W&D market

Forecast of the big three US wholesalers from 2008-2013

Drivers and restraints facing the W&D market

Opportunities and threats facing the W&D market

Commercial prospects for the W&D market

Discussion of unmet needs

This report examines the industry critically through a comprehensive review of available information, including that from commercial databases and other highly relevant sources, including SWOT analysis. Visiongain applies financial forecasting, qualitative analyses and the assessment of unmet needs to provide a comprehensive market report with detailed analysis and informed opinion.

Why you should buy this report:

To receive a comprehensive analysis of the prospects for the W&D market

To discover predicted revenues, growth rates and other key metrics for the big three US wholesalers from 2008-2013

To determine key activities of leading pharmaceutical manufacturers

To determine the forces that influence the W&D market

Competitive characteristics of the market

Drivers

Restraints

Strengths, weaknesses, opportunities and threats (SWOT analysis)

To find out where the W&D industry is heading - both technologically and commercially

For more information, please contact :

http://www.aarkstore.com/reports/The-Pharmaceutical-Wholesale-and-Distribution-Industry-Outlook-Analysis-2008-33091.html

by: aarkstore enterprise

POST COMMENT

Aarkstore Enterprise---doosan Heavy Industries & Construction Co., Ltd. (34020) - Financial And Stra Key Players In The Global Additives Industry--- Aarkstore Enterprise Syncrude, Canada, Commercial Asset Valuation And Forecast To 2057 - Aarkstore Enterprise Alve, Norway, Commercial Asset Valuation And Forecast To 2021 - Aarkstore Enterprise Blake, United Kingdom, Commercial Asset Valuation And Forecast To 2015 - Aarkstore Enterprise Block 17, Angola, Commercial Asset Valuation And Forecast To 2030 - Aarkstore Enterprise Block 18, East Zone, Angola, Commercial Asset Valuation And Forecast To 2027 - Aarkstore Enterprise Bonga Field, Nigeria, Commercial Asset Valuation And Forecast To 2025 - Aarkstore Enterprise Bruce Field, United Kingdom, Commercial Asset Valuation And Forecast To 2021 - Aarkstore Enterprise Buzzard Field, United Kingdom, Commercial Asset Valuation And Forecast To 2027 - Aarkstore Callanish, United Kingdom, Commercial Asset Valuation And Forecast To 2022 - Aarkstore Enterprise Cano Limon, Colombia, Commercial Asset Valuation And Forecast To 2031 - Aarkstore Enterprise Captain Field, United Kingdom, Commercial Asset Valuation And Forecast To 2016 - Aarkstore Enterpris